Clinical trial
A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study
NCT00321009 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study
- Lead sponsor
- Corewell Health East
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2000
- Completion date
- April 30, 2004
- Enrollment
- 60
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction, coronary artery disease